冠状动脉病理生理与缺血性心脏病的性别差异
本科学声明系统回顾了缺血性心脏病从危险因素到预后的性别差异。女性更易发生微血管疾病和内皮功能障碍,但在相似冠脉狭窄程度下心肌缺血反而较轻。诊断工具常存在男性中心偏倚,女性诊断不足且较少接受指南推荐治疗,年轻女性合并阻塞性冠脉病变的急性冠脉综合征预后更差。
要点
- 女性更易发生冠脉微血管疾病和内皮功能障碍,但相似狭窄程度下心肌缺血较轻。
- 诊断工具存在男性中心偏倚,导致女性诊断不足且治疗不充分。
- 年轻女性合并阻塞性冠脉病变的急性冠脉综合征预后更差。
核心结论
- 缺血性心脏病在男性和女性之间存在重要差异,需要理解这些差异以改善预后。
- 女性更易发生微血管疾病和内皮功能障碍,但在相似冠脉狭窄程度下心肌缺血反而较轻。
- 年轻女性合并阻塞性冠脉病变的急性冠脉综合征预后更差。
研究设计与样本
- 本文为欧洲心脏杂志发表的科学声明,提供从危险因素到预后的当前知识更新综述。
- 文中指出女性在随机对照试验中的入组率较低。
主要发现
- 某些传统危险因素对男性和女性的影响程度不同。
- 激素变化和治疗(包括跨性别人群和癌症患者)、妊娠相关并发症及自身免疫性疾病构成性别特异性风险谱。
- 病理生理方面存在功能和结构性性别差异,如冠脉粥样斑块和负荷、冠脉夹层、血管痉挛和微血管疾病。
- 诊断工具常存在男性中心偏倚,导致女性诊断不足,且女性较少接受指南推荐治疗。
- 女性对各种预防和治疗措施可能有不同反应和副作用。
临床怎么用
- 需要开展针对性别的专门研究以弥补知识缺口。
- 应关注女性特有的危险因素,包括激素变化、妊娠并发症和自身免疫性疾病。
- 临床实践中应减少诊断工具的男性中心偏倚,提高女性诊断率和指南推荐治疗的实施率。
局限性
- 女性在随机对照试验中的入组率较低,难以明确女性最佳治疗方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ischaemic heart disease shows important differences between men and women, requiring an understanding of sex and gender dissimilarities to improve outcomes. This Scientific Statement provides an updated review of the current knowledge from risk factors to prognosis. It discusses the unequal impact of certain traditional risk factors between men and women, along with additional factors, such as hormonal changes and treatments (including those for transgender people and cancer), pregnancy-related complications, and autoimmune diseases, which contribute to the sex-specific risk profiles. Moreover, it outlines functional and structural sex differences in the pathophysiology (e.g. coronary atheroma plaques and burden, coronary dissection, vasospasm, and microvascular disease) with women being more prone to microvascular disease and endothelial dysfunction, while paradoxically experiencing less severe myocardial ischaemia at similar levels of coronary stenosis. The document further addresses the evaluation of diagnostic tools, which often have a male-centric bias, resulting in underdiagnosis in women who also tend to receive less guideline-recommended treatment. Additionally, women can have different responses and side effects to various preventive and therapeutic treatments, potentially contributing to the worse prognosis documented in acute coronary syndromes with obstructive coronary artery disease, particularly at a young age. Considering all these sex and gender differences and the low enrolment of women in randomized controlled trials, questions arise regarding the optimal treatment for women. Addressing sex differences requires conducting sex-specific research to close the knowledge gap. Overall, the Scientific Statement highlights all relevant sex- and gender-specific dissimilarities to advance clinical practice and identify directions for future research to improve guideline recommendations for equitable care.
引用
- Manfrini, Tousoulis, Antoniades, et al. Sex and gender differences in coronary pathophysiology and ischaemic heart disease. Eur Heart J. 2026. PMID: 41571335. doi:10.1093/eurheartj/ehaf1059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。